NASDAQ:GEHC 7 December 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

GE HealthCare is acquiring Intelerad for $2.3 billion and launching new NVIDIA-powered MRI and CT platforms, including the Signa One system, at RSNA 2025. The company reported stronger-than-expected Q3 earnings, raised its 2025 profit outlook, and saw institutional investors maintain high ownership. Shares closed near $85.46, valuing the firm at $39 billion.

7 December 2025

Artificial Intelligence·NASDAQ:GEHC·Stock Market

Altria Shares Rise Amid FDA Tobacco Rule and Increased Trading Volumes
June 27, 2026, 6:10 PM EDT. Altria Group (NYSE:MO) shares climbed 0.79% to $73.79 on June 26, driven by a five-day rally that boosted the stock nearly 6.8%, narrowing the gap to its 52-week high. The surge reduced Altria's dividend yield to approximately 5.75% from 6.13%, as the stock price outpaced the fixed quarterly payout. Trading volume spiked 75% above the 65-day average amid FTSE Russell's index rebalancing and heightened market activity. The U.S. Food and Drug Administration proposed new rules requiring foreign tobacco companies to register facilities and list products, raising regulatory considerations. Despite broader market declines, Altria outperformed with a low beta of 0.46, suggesting targeted investor demand.

Altria Group (NYSE:MO) shares climb, pressuring yield spread as FDA rule draws talk on volumes

27 June 2026

Altria surged 6.8% last week to $73.79, just 1% below its 52-week high, adding $7.8 billion in equity value even as the S&P 500 fell 2.05%; investors face a fresh regulatory risk/reward calculus after the FDA proposed new rules for foreign tobacco makers, while heavy trading volume was driven in part by the Russell index reset.

Accenture (NYSE:ACN) holds firm after selloff as cyber deal at 20x tests reset

27 June 2026

Accenture surged 2.51% to $128.98 Friday but remains 58% below its 52-week high, as Wall Street slashed price targets after mixed Q3 results and a $4.175 billion cyber deal valued at 20 times expected ARR; analysts cite weak demand and slow AI scaling, with the stock trading near 9.3 times 2026 EPS guidance.

GE Vernova (NYSE:GEV) stock ends volatile week with failed bounce before U.S. holiday break

27 June 2026

GE Vernova (NYSE:GEV) plunged 3.71% to $1,045.17 Friday, erasing 80% of its midweek rebound and capping a 7.31% weekly loss—about $22.1 billion in equity value—despite strong demand signals and a major Chevron-Microsoft turbine project announcement; investors await Q2 earnings July 22 for proof of backlog conversion.

NASDAQ:GEHC 7 December 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

Stock Market Today

Latest articles

Altria Group (NYSE:MO) shares climb, pressuring yield spread as FDA rule draws talk on volumes

Accenture (NYSE:ACN) holds firm after selloff as cyber deal at 20x tests reset

GE Vernova (NYSE:GEV) stock ends volatile week with failed bounce before U.S. holiday break

Latest Video